0.4010
-0.0990
(-19.80%)
As of 5:18:46 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,266.0000
4,440.0000
12,788.0000
9,335.0000
243.0000
Cost of Revenue
5,078.0000
3,445.0000
34,168.0000
34,364.0000
32,262.0000
Gross Profit
-2,812.0000
995.0000
-21,380.0000
-25,029.0000
-32,019.0000
Operating Expense
215,209.0000
231,729.0000
241,484.0000
206,740.0000
189,474.0000
Operating Income
-218,021.0000
-230,734.0000
-262,864.0000
-231,769.0000
-221,493.0000
Net Non Operating Interest Income Expense
-3,247.0000
-1,569.0000
629.0000
899.0000
2,887.0000
Pretax Income
-218,333.0000
-229,366.0000
-268,694.0000
-231,435.0000
-218,655.0000
Net Income Common Stockholders
-218,333.0000
-229,366.0000
-268,694.0000
-231,435.0000
-218,655.0000
Diluted NI Available to Com Stockholders
-218,333.0000
-229,366.0000
-268,694.0000
-231,435.0000
-218,655.0000
Basic EPS
-1.29
-3.48
-9.20
-8.20
-8.64
Diluted EPS
-1.29
-3.48
-9.20
-8.20
-8.64
Basic Average Shares
116,977.7250
65,941.3900
29,209.4750
28,239.0640
25,309.0410
Diluted Average Shares
116,977.7250
65,941.3900
29,209.4750
28,239.0640
25,309.0410
Total Operating Income as Reported
-217,876.0000
-230,587.0000
-262,247.0000
-232,033.0000
-221,543.0000
Rent Expense Supplemental
--
--
--
--
6,329.0000
Total Expenses
220,287.0000
235,174.0000
275,652.0000
241,104.0000
221,736.0000
Net Income from Continuing & Discontinued Operation
-218,333.0000
-229,366.0000
-268,694.0000
-231,435.0000
-218,655.0000
Normalized Income
-221,741.0000
-232,774.0000
-261,618.0000
-231,135.0000
-218,655.0000
Interest Income
--
--
1,348.0000
1,668.0000
4,423.0000
Interest Expense
1,894.0000
1,569.0000
719.0000
769.0000
1,536.0000
Net Interest Income
-3,247.0000
-1,569.0000
629.0000
899.0000
2,887.0000
EBIT
-216,439.0000
-227,797.0000
-267,975.0000
-230,666.0000
-217,119.0000
EBITDA
-198,629.0000
-210,276.0000
-252,689.0000
-218,478.0000
-211,018.0000
Reconciled Cost of Revenue
5,078.0000
3,445.0000
34,168.0000
34,364.0000
32,262.0000
Reconciled Depreciation
17,810.0000
17,521.0000
15,286.0000
12,188.0000
6,101.0000
Net Income from Continuing Operation Net Minority Interest
-218,333.0000
-229,366.0000
-268,694.0000
-231,435.0000
-218,655.0000
Total Unusual Items Excluding Goodwill
3,408.0000
3,408.0000
-7,076.0000
-300.0000
--
Total Unusual Items
3,408.0000
3,408.0000
-7,076.0000
-300.0000
--
Normalized EBITDA
-202,037.0000
-213,684.0000
-245,613.0000
-218,178.0000
-211,018.0000
12/31/2020 - 12/7/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MONI.ST Monivent AB
0.3180
+1.92%
XVIVO.ST Xvivo Perfusion AB (publ)
440.00
-7.47%
IMP-A-SDB.ST Implantica AG
36.40
-4.59%
ACARIX.ST Acarix AB (publ)
0.2480
-0.60%
QLIFE.ST Qlife Holding AB (publ)
2.3200
+9.43%
NYZ.BE Novacyt SA
0.6880
+1.62%
CRBX.ST Carbiotix AB
11.10
-1.77%
BACTI-B.ST Bactiguard Holding AB (publ)
37.00
+3.35%
CYBQF CYBERDYNE Inc.
1.0350
0.00%
TENDO.ST Tendo AB
0.0116
-9.37%